- Report
- October 2024
- 198 Pages
Global
From €3503EUR$3,545USD£2,915GBP
€3892EUR$3,939USD£3,239GBP
- Report
- February 2024
- 250 Pages
Global
From €4940EUR$5,000USD£4,112GBP
- Report
- November 2024
- 403 Pages
Global
From €5533EUR$5,600USD£4,605GBP
- Report
- September 2024
- 150 Pages
Global
From €4792EUR$4,850USD£3,989GBP
- Report
- August 2024
- 135 Pages
Global
From €3903EUR$3,950USD£3,248GBP
- Report
- July 2024
- 148 Pages
Global
From €3853EUR$3,899USD£3,207GBP
- Report
- February 2024
- 115 Pages
Global
From €4693EUR$4,750USD£3,906GBP
- Report
- June 2024
- 200 Pages
Global
From €5499EUR$5,565USD£4,577GBP
€7855EUR$7,950USD£6,538GBP
- Drug Pipelines
- June 2024
- 160 Pages
Global
From €2964EUR$3,000USD£2,467GBP
- Report
- October 2024
Global
From €3903EUR$3,950USD£3,248GBP
- Report
- October 2024
- 196 Pages
Global
From €3503EUR$3,545USD£2,915GBP
€3892EUR$3,939USD£3,239GBP
- Report
- October 2024
- 180 Pages
Global
From €3503EUR$3,545USD£2,915GBP
€3892EUR$3,939USD£3,239GBP
- Report
- October 2024
- 185 Pages
Global
From €3503EUR$3,545USD£2,915GBP
€3892EUR$3,939USD£3,239GBP
- Report
- October 2024
- 181 Pages
Global
From €3503EUR$3,545USD£2,915GBP
€3892EUR$3,939USD£3,239GBP
- Report
- September 2024
- 175 Pages
Global
From €4940EUR$5,000USD£4,112GBP
- Report
- August 2024
- 175 Pages
Global
From €4940EUR$5,000USD£4,112GBP
- Report
- February 2024
- 175 Pages
Global
From €4940EUR$5,000USD£4,112GBP
- Report
- February 2024
- 175 Pages
Global
From €4940EUR$5,000USD£4,112GBP
- Report
- September 2024
- 150 Pages
Global
From €4792EUR$4,850USD£3,989GBP
- Report
- July 2024
- 150 Pages
Global
From €4792EUR$4,850USD£3,989GBP
The Cancer Vaccines market is a rapidly growing sector of the healthcare industry. It is focused on the development of vaccines to prevent and treat cancer. These vaccines are designed to stimulate the body's immune system to recognize and attack cancer cells. The goal is to reduce the risk of cancer recurrence and improve the quality of life for cancer patients.
The Cancer Vaccines market is composed of a variety of companies, ranging from large pharmaceutical companies to small biotechnology firms. These companies are involved in the research, development, and production of cancer vaccines. They are also involved in clinical trials to test the safety and efficacy of these vaccines.
Some of the major players in the Cancer Vaccines market include Merck, GlaxoSmithKline, Pfizer, Sanofi, and Johnson & Johnson. These companies are actively involved in the development of cancer vaccines and are working to bring new treatments to the market. Show Less Read more